NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | 0.0% | 285 | +13.5% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 251 | +151.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 100 | +49.3% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 67 | +17.5% | 0.00% | – |
Q4 2019 | $1,000 | -50.0% | 57 | -52.5% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 120 | +531.6% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 19 | -5.0% | 0.00% | – |
Q3 2018 | $1,000 | – | 20 | +5.3% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 19 | -95.4% | 0.00% | -100.0% |
Q1 2018 | $44,000 | +83.3% | 412 | +2.5% | 0.01% | +66.7% |
Q4 2017 | $24,000 | – | 402 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |